Fuster-Lluch O, Gerónimo-Pardo M, Peyró-García R, Lizán-García M
Department of Clinical Analysis, Complejo Hospitalario Universitario of Albacete, Albacete, Spain.
Anaesth Intensive Care. 2008 Sep;36(5):674-80. doi: 10.1177/0310057X0803600507.
Glomerular hyperfiltration and albuminuria are two pathological conditions that could alter renal drug elimination, but they have been rarely studied in a critical care setting. The aims of this descriptive, prospective study performed on 89 critically ill patients are to determine rates of glomerular hyperfiltration (main objective) and albuminuria (secondary objective). On admission, 17.9% of patients presented with glomerular hyperfiltration, climbing to rates as high as 30% during the first week of admission. Seventy-five percent showed albuminuria on admission, with rates remaining high throughout the week of the study. Since glomerular hyperfiltration as well as albuminuria are frequent pathophysiological conditions in critical care patients, the implications that these phenomena may have regarding drug elimination need further evaluation.
肾小球高滤过和蛋白尿是两种可能改变肾脏药物清除的病理状况,但在重症监护环境中对它们的研究很少。这项对89例重症患者进行的描述性前瞻性研究的目的是确定肾小球高滤过率(主要目标)和蛋白尿发生率(次要目标)。入院时,17.9%的患者出现肾小球高滤过,入院第一周时这一比例攀升至高达30%。75%的患者入院时出现蛋白尿,在研究的整周内发生率一直很高。由于肾小球高滤过和蛋白尿在重症监护患者中是常见的病理生理状况,这些现象对药物清除可能产生的影响需要进一步评估。